News tagged with levodopa
L-DOPA
L-DOPA (L-3,4-dihydroxyphenylalanine) is a chemical that is made and used as part of the normal biology of some animals and plants. Some animals including humans make it via biosynthesis from the amino acid L-tyrosine. L-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) collectively known as catecholamines. L-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc.). As a drug it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
For more information about L-DOPA, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Chinese medicine could treat Parkinson's: HK study
Chinese medicine may be effective in battling certain symptoms of Parkinson's disease, and lessening side effects from the drugs used to treat the condition, according to a new study.
Medicine & Health / Medications
Jul 21, 2011 |
not rated yet |
0
Investigational drug may reduce involuntary movements
Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will ...
Medicine & Health / Neuroscience
Apr 12, 2011 |
not rated yet |
0
Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinson's disease
Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson's disease receiving standard dopamine therapy, an international study led by the University of South Florida found.
Medicine & Health / Neuroscience
Feb 10, 2011 |
not rated yet |
0
Parkinson's disease treatment strategies appear to have similar long-term effects on disability
Patients with early Parkinson disease appear to have similar overall levels of disability and quality of life six years after beginning treatment with either levodopa or a dopamine agonist, according to a report posted online ...
Medicine & Health / Neuroscience
Mar 09, 2009 |
not rated yet |
0
Search results for levodopa
Scientists identify protein that contributes to symptoms of Parkinson's disease
Scientists at the Gladstone Institutes, an independent and nonprofit biomedical-research organization, have identified a protein that exacerbates symptoms of Parkinson's disease—a discovery that could one day lead to ...
Medicine & Health / Neuroscience
Jan 25, 2012 |
4.7 / 5 (3) |
0
|
Parkinson's treatment shows positive results in clinical testing
Researchers from the University of Florida and 14 additional medical centers reported results today in the online version of The Lancet Neurology journal indicating that deep brain stimulation — also known as DBS &# ...
Medicine & Health / Neuroscience
Jan 11, 2012 |
5 / 5 (1) |
0
|
On the road: Bike riding helps Parkinson's diagnosis
Neurologists examining a patient with early symptoms of Parkinson's disease should ask that individual to ride a bike, according to unusual research by Dutch doctors.
Jan 07, 2011 |
not rated yet |
0
Fatigue and excessive daytime sleepiness should be assessed separately in Parkinson's
Nearly three-quarters of patients with Parkinson's disease experience fatigue or excessive daytime sleepiness (EDS), but clinicians should assess both problems separately in order to improve the profession's understanding ...
Dec 01, 2010 |
not rated yet |
0
Brain scans show effects of Parkinson's drug
Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson's disease get into a patient's brain and affect blood flow in several key structures, an indicator the drug ...
Medicine & Health / Neuroscience
Nov 30, 2010 |
4.5 / 5 (2) |
0
|
New discovery in Parkinson's research
A major lead for potential new treatment for people with Parkinson's Disease has been discovered by a team at Cardiff University.
Medicine & Health / Neuroscience
Nov 24, 2010 |
4 / 5 (4) |
0
Trial Studies New Way to Deliver Parkinson's Medication
(PhysOrg.com) -- Most medications for Parkinson's disease are taken orally, at certain times of the day. But doctors at UC Health University Hospital are participating in a clinical trial that significantly changes the Parkinson's ...
Medicine & Health / Medications
Aug 05, 2010 |
not rated yet |
0
Expectations may affect placebo response in patients with Parkinson's disease
Individuals with Parkinson's disease were more likely to have a neurochemical response to a placebo medication if they were told they had higher odds of receiving an active drug, according to a report in the August issue ...
Medicine & Health / Psychology & Psychiatry
Aug 02, 2010 |
not rated yet |
0
Parkinson's Patients More Likely to Stick With Certain 'Add-on' Drugs
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson’s disease, one might be the most effective, according to a new review.
Jul 09, 2010 |
not rated yet |
0
Parkinson's disease treatments associated with compulsive behaviors
Pathological gambling, compulsive shopping, binge eating and other impulse control disorders appear to be more common among individuals taking dopamine agonist medications for Parkinson's disease, according to a report in ...
May 10, 2010 |
not rated yet |
0
List of search results for levodopa
